These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5013376)

  • 1. Enhanced absorption and dissolution of reserpine from reserpine-polyvinylpyrrolidone coprecipitates.
    Stupak EI; Bates TR
    J Pharm Sci; 1972 Mar; 61(3):400-4. PubMed ID: 5013376
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced absorption of digitoxin from orally administered digitoxin-polyvinylpyrrolidone coprecipitates.
    Stupak EI; Bates TR
    J Pharm Sci; 1973 Nov; 62(11):1806-9. PubMed ID: 4758077
    [No Abstract]   [Full Text] [Related]  

  • 3. Biopharmaceutical and physiocochemical studies on reserpine-polyvinylpyrrolidone coprecipitates.
    Stupak EI; Rosenberg HA; Bates TR
    J Pharmacokinet Biopharm; 1974 Dec; 2(6):511-24. PubMed ID: 4461781
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate.
    Sekikawa H; Fujiwara J; Naganuma T; Nakano M; Arita T
    Chem Pharm Bull (Tokyo); 1978 Oct; 26(10):3033-9. PubMed ID: 729106
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissolution mechanisms of drug-polyvinylpyrrolidone coprecipitates in aqueous solution.
    Sekikawa H; Nakano M; Arita T
    Chem Pharm Bull (Tokyo); 1979 May; 27(5):1223-30. PubMed ID: 498375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preparation and dissolution study of daidzein-PVP coprecipitates].
    Tang LJ; Qiao PX; Zhang LY
    Yao Xue Xue Bao; 1989; 24(10):778-82. PubMed ID: 2618670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution characteristics of reserpine-polyvinylpyrrolidone co-precipitates.
    Bates TR
    J Pharm Pharmacol; 1969 Oct; 21(10):710-2. PubMed ID: 4390622
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved oral absorption of enteric coprecipitates of a poorly soluble drug.
    Kondo N; Iwao T; Hirai K; Fukuda M; Yamanouchi K; Yokoyama K; Miyaji M; Ishihara Y; Kon K; Ogawa Y
    J Pharm Sci; 1994 Apr; 83(4):566-70. PubMed ID: 8046616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution and in vivo absorption of nitrofurantoin from deoxycholic acid coprecipitates.
    Stoll RG; Bates TR; Swarbrick J
    J Pharm Sci; 1973 Jan; 62(1):65-8. PubMed ID: 4682935
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral absorption of atorvastatin solid dispersion based on cellulose or pyrrolidone derivative polymers.
    Kim MS; Kim JS; Cho W; Park HJ; Hwang SJ
    Int J Biol Macromol; 2013 Aug; 59():138-42. PubMed ID: 23567288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dissolution properties and gastrointestinal absorption of chloramphenicol from hydrophilic high molecular compound coprecipitates (author's transl)].
    Moriyama M; Inoue A; Isoya M; Tanaka M; Hanano M
    Yakugaku Zasshi; 1978 Aug; 98(8):1012-8. PubMed ID: 712564
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dissolution behaviors and gastrointestinal absorption of sulfisoxazole in sulfisoxazole-polyvinylpyrrolidone coprecipitate (author's transl)].
    Sekikawa H; Nakano M; Arita T
    Yakugaku Zasshi; 1978 Jan; 98(1):62-6. PubMed ID: 641703
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interactions between macromolecular adjuvants and drugs. Part 17: On the effect of macromolecular adjuvants on the dissolution rate of chlorpromazine from dosage forms (author's transl)].
    Voigt R; Gulde C; Sacher E
    Pharmazie; 1979; 34(3):168-71. PubMed ID: 450957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution kinetics for coprecipitates of diflunisal with PVP K30.
    Rodríguez-Espinosa C; Martínez-Ohárriz MC; Martín C; Goñi MM; Vélaz I; Sánchez M
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):109-12. PubMed ID: 9725466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of controlled release captopril granules coated with ethylcellulose and methylcellulose by fluid bed dryer.
    Stulzer HK; Silva MA; Fernandes D; Assreuy J
    Drug Deliv; 2008 Jan; 15(1):11-8. PubMed ID: 18197518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates.
    Simonelli AP; Mehta SC; Higuchi WI
    J Pharm Sci; 1969 May; 58(5):538-49. PubMed ID: 5796439
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissolution behavior and gastrointestinal absorption of sulfamethoxazole from sulfamethoxazole-polyvinylpyrrolidone coprecipitates.
    Sekikawa H; Yagi N; Sakuragi J; Tanaka M; Sakamoto M; Itoh M; Takada M; Arita T
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):739-43. PubMed ID: 7094156
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interaction between macromolecular adjuvants and drugs. 24. Improvement of the solubility characteristics of benzodiazepine derivatives with polyvinylpyrrolidone].
    Keipert S; Voigt R
    Pharmazie; 1986 Jun; 41(6):400-4. PubMed ID: 2876444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of polyvinylpyrrolidone on the dissolution properties of hydroflumethiazide.
    Corrigan OI; Timoney RF
    J Pharm Pharmacol; 1975 Oct; 27(10):759-64. PubMed ID: 241789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some physical factors affecting the enhanced blepharoptotic activity of orally administered reserpine-cholanic acid coprecipitates.
    Stoll RG; Bates TR; Nieforth KA; Swarbrick J
    J Pharm Sci; 1969 Dec; 58(12):1457-9. PubMed ID: 5353258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.